Work has begun on a new £6 million state-ofthe- art hybrid endovascular theatre suite set to transform the treatment of patients undergoing minimally invasive cardiovascular procedures at Central Manchester University Hospitals NHS Foundation Trust.
It will be the first hospital in the UK to have two adjacent fully hybrid theatres utilising a robotic imaging system with fully flexible theatre table. Only a few such facilities exist worldwide.
Situated in Manchester Royal Infirmary, the two theatres will provide a dedicated facility with state-of-the-art technology. This includes high definition imaging with a robotic arm as well as facilities for traditional surgery all in one place. The hybrid suite will provide better facilities where existing techniques can be performed more efficiently and safely. It will also enable new innovative techniques and treatments to be carried out that are not currently possible.
Mr David Murray, consultant vascular surgeon at Manchester Royal Infirmary, said: “This facility will be a fantastic resource for the people of Manchester and the North West. It will allow us to perform complex procedures in a safer environment and will bring a great many benefits to our patients. Minimally invasive treatments will allow patients to have safer surgery and recover much faster. This really is the cutting edge of technology and we are very excited about the future.”
The new hybrid suite will be used primarily for vascular and cardiac surgery but will also be used for other specialties such as urology and major trauma. The new theatres are due for completion in April 2014.
